Gonadotropin-releasing hormone (GnRH) gene regulation by N-methyl-D-aspartic acid in GT1-1 neuronal cells

Differential involvement of c-fos and c-jun protooncogenes

Neoncheol Jung, Woong Sun, Hojoon Lee, Sehyung Cho, Chanseob Shim, Kyungjin Kim

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

The present study examined the regulatory mechanisms of GnRH gene expression by N-methyl-d-aspartic acid (NMDA) in immortalized hypothalamic GnRH neurons (GT1-1 cells). NMDA (100 μM) stimulated GnRH mRNA levels transiently at 2 h after treatment. Dose-response experiment showed that there was a biphasic action of NMDA on GnRH mRNA levels: GnRH mRNA levels were increased by NMDA at lower concentrations (10 and 100 μM), but not at higher concentrations (1 and 10 mM). NMDA (100 μM)-induced GnRH mRNA levels were efficiently blocked by pre-treatment with NMDA receptor antagonists, MK-801 and AP-5. We next examined the signal transduction pathways involved in NMDA-induced GnRH gene expression based on previous findings that NMDA signal propagates into the cell through Ca2+ and nitric oxide (NO) pathways in many neurons. While ionomycin, a Ca2+ ionopore, application failed to alter GnRH gene expression, treatment of GT1-1 cells with sodium nitroprusside (SNP), an NO donor, increased GnRH gene expression with a similar time course to NMDA treatment. Moreover, application of GT1-1 cells with nitric oxide synthase (NOS) inhibitors (l-NAME, d-NAME, and NA) prior to NMDA treatment, inhibited NMDA-induced GnRH gene expression. These results indicate that the effect of NMDA is mediated by the NO signalling cascade. The mouse GnRH promoter activity was also increased by NMDA at low concentration (100 μM), but not at high concentration (1 μM), confirming the biphasic action of NMDA on GnRH mRNA levels. Since NMDA (100 μM) and SNP (1 μM) markedly induced c-jun expression, but not c-fos expression, we hypothesized that Jun activation is responsible for the transcriptional activation of GnRH gene expression. To examine this, we performed two different experiments. Treatment of NMDA greatly increased the activity of heterologous promoter of Fos/Jun responsive sequence (-187/-69) from the mouse GnRH promoter fused to hsv-tk minimal promoter. Moreover, overexpression of c-jun induced GnRH promoter activity, while c-fos overexpression decreased GnRH promoter activity. Taken together, this study indicates that NMDA regulates GnRH gene expression in GT1-1 cells through the NO-Jun signal transduction pathway. Copyright (C) 1998 Elsevier Science B.V.

Original languageEnglish
Pages (from-to)162-169
Number of pages8
JournalMolecular Brain Research
Volume61
Issue number1-2
DOIs
Publication statusPublished - 1998 Oct 30
Externally publishedYes

Fingerprint

N-Methylaspartate
Gonadotropin-Releasing Hormone
Aspartic Acid
Genes
Gene Expression
Messenger RNA
Nitric Oxide
Nitroprusside
Signal Transduction
Pituitary Hormone-Releasing Hormones
Neurons
Ionomycin
Dizocilpine Maleate
Nitric Oxide Donors
Nitric Oxide Synthase
Transcriptional Activation

Keywords

  • Fos
  • GnRH
  • GT1-1 cell
  • Jun
  • Nitric oxide
  • NMDA

ASJC Scopus subject areas

  • Molecular Biology
  • Cellular and Molecular Neuroscience

Cite this

Gonadotropin-releasing hormone (GnRH) gene regulation by N-methyl-D-aspartic acid in GT1-1 neuronal cells : Differential involvement of c-fos and c-jun protooncogenes. / Jung, Neoncheol; Sun, Woong; Lee, Hojoon; Cho, Sehyung; Shim, Chanseob; Kim, Kyungjin.

In: Molecular Brain Research, Vol. 61, No. 1-2, 30.10.1998, p. 162-169.

Research output: Contribution to journalArticle

@article{49129d7524824d389f56a7a1b1caf76c,
title = "Gonadotropin-releasing hormone (GnRH) gene regulation by N-methyl-D-aspartic acid in GT1-1 neuronal cells: Differential involvement of c-fos and c-jun protooncogenes",
abstract = "The present study examined the regulatory mechanisms of GnRH gene expression by N-methyl-d-aspartic acid (NMDA) in immortalized hypothalamic GnRH neurons (GT1-1 cells). NMDA (100 μM) stimulated GnRH mRNA levels transiently at 2 h after treatment. Dose-response experiment showed that there was a biphasic action of NMDA on GnRH mRNA levels: GnRH mRNA levels were increased by NMDA at lower concentrations (10 and 100 μM), but not at higher concentrations (1 and 10 mM). NMDA (100 μM)-induced GnRH mRNA levels were efficiently blocked by pre-treatment with NMDA receptor antagonists, MK-801 and AP-5. We next examined the signal transduction pathways involved in NMDA-induced GnRH gene expression based on previous findings that NMDA signal propagates into the cell through Ca2+ and nitric oxide (NO) pathways in many neurons. While ionomycin, a Ca2+ ionopore, application failed to alter GnRH gene expression, treatment of GT1-1 cells with sodium nitroprusside (SNP), an NO donor, increased GnRH gene expression with a similar time course to NMDA treatment. Moreover, application of GT1-1 cells with nitric oxide synthase (NOS) inhibitors (l-NAME, d-NAME, and NA) prior to NMDA treatment, inhibited NMDA-induced GnRH gene expression. These results indicate that the effect of NMDA is mediated by the NO signalling cascade. The mouse GnRH promoter activity was also increased by NMDA at low concentration (100 μM), but not at high concentration (1 μM), confirming the biphasic action of NMDA on GnRH mRNA levels. Since NMDA (100 μM) and SNP (1 μM) markedly induced c-jun expression, but not c-fos expression, we hypothesized that Jun activation is responsible for the transcriptional activation of GnRH gene expression. To examine this, we performed two different experiments. Treatment of NMDA greatly increased the activity of heterologous promoter of Fos/Jun responsive sequence (-187/-69) from the mouse GnRH promoter fused to hsv-tk minimal promoter. Moreover, overexpression of c-jun induced GnRH promoter activity, while c-fos overexpression decreased GnRH promoter activity. Taken together, this study indicates that NMDA regulates GnRH gene expression in GT1-1 cells through the NO-Jun signal transduction pathway. Copyright (C) 1998 Elsevier Science B.V.",
keywords = "Fos, GnRH, GT1-1 cell, Jun, Nitric oxide, NMDA",
author = "Neoncheol Jung and Woong Sun and Hojoon Lee and Sehyung Cho and Chanseob Shim and Kyungjin Kim",
year = "1998",
month = "10",
day = "30",
doi = "10.1016/S0169-328X(98)00227-7",
language = "English",
volume = "61",
pages = "162--169",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Gonadotropin-releasing hormone (GnRH) gene regulation by N-methyl-D-aspartic acid in GT1-1 neuronal cells

T2 - Differential involvement of c-fos and c-jun protooncogenes

AU - Jung, Neoncheol

AU - Sun, Woong

AU - Lee, Hojoon

AU - Cho, Sehyung

AU - Shim, Chanseob

AU - Kim, Kyungjin

PY - 1998/10/30

Y1 - 1998/10/30

N2 - The present study examined the regulatory mechanisms of GnRH gene expression by N-methyl-d-aspartic acid (NMDA) in immortalized hypothalamic GnRH neurons (GT1-1 cells). NMDA (100 μM) stimulated GnRH mRNA levels transiently at 2 h after treatment. Dose-response experiment showed that there was a biphasic action of NMDA on GnRH mRNA levels: GnRH mRNA levels were increased by NMDA at lower concentrations (10 and 100 μM), but not at higher concentrations (1 and 10 mM). NMDA (100 μM)-induced GnRH mRNA levels were efficiently blocked by pre-treatment with NMDA receptor antagonists, MK-801 and AP-5. We next examined the signal transduction pathways involved in NMDA-induced GnRH gene expression based on previous findings that NMDA signal propagates into the cell through Ca2+ and nitric oxide (NO) pathways in many neurons. While ionomycin, a Ca2+ ionopore, application failed to alter GnRH gene expression, treatment of GT1-1 cells with sodium nitroprusside (SNP), an NO donor, increased GnRH gene expression with a similar time course to NMDA treatment. Moreover, application of GT1-1 cells with nitric oxide synthase (NOS) inhibitors (l-NAME, d-NAME, and NA) prior to NMDA treatment, inhibited NMDA-induced GnRH gene expression. These results indicate that the effect of NMDA is mediated by the NO signalling cascade. The mouse GnRH promoter activity was also increased by NMDA at low concentration (100 μM), but not at high concentration (1 μM), confirming the biphasic action of NMDA on GnRH mRNA levels. Since NMDA (100 μM) and SNP (1 μM) markedly induced c-jun expression, but not c-fos expression, we hypothesized that Jun activation is responsible for the transcriptional activation of GnRH gene expression. To examine this, we performed two different experiments. Treatment of NMDA greatly increased the activity of heterologous promoter of Fos/Jun responsive sequence (-187/-69) from the mouse GnRH promoter fused to hsv-tk minimal promoter. Moreover, overexpression of c-jun induced GnRH promoter activity, while c-fos overexpression decreased GnRH promoter activity. Taken together, this study indicates that NMDA regulates GnRH gene expression in GT1-1 cells through the NO-Jun signal transduction pathway. Copyright (C) 1998 Elsevier Science B.V.

AB - The present study examined the regulatory mechanisms of GnRH gene expression by N-methyl-d-aspartic acid (NMDA) in immortalized hypothalamic GnRH neurons (GT1-1 cells). NMDA (100 μM) stimulated GnRH mRNA levels transiently at 2 h after treatment. Dose-response experiment showed that there was a biphasic action of NMDA on GnRH mRNA levels: GnRH mRNA levels were increased by NMDA at lower concentrations (10 and 100 μM), but not at higher concentrations (1 and 10 mM). NMDA (100 μM)-induced GnRH mRNA levels were efficiently blocked by pre-treatment with NMDA receptor antagonists, MK-801 and AP-5. We next examined the signal transduction pathways involved in NMDA-induced GnRH gene expression based on previous findings that NMDA signal propagates into the cell through Ca2+ and nitric oxide (NO) pathways in many neurons. While ionomycin, a Ca2+ ionopore, application failed to alter GnRH gene expression, treatment of GT1-1 cells with sodium nitroprusside (SNP), an NO donor, increased GnRH gene expression with a similar time course to NMDA treatment. Moreover, application of GT1-1 cells with nitric oxide synthase (NOS) inhibitors (l-NAME, d-NAME, and NA) prior to NMDA treatment, inhibited NMDA-induced GnRH gene expression. These results indicate that the effect of NMDA is mediated by the NO signalling cascade. The mouse GnRH promoter activity was also increased by NMDA at low concentration (100 μM), but not at high concentration (1 μM), confirming the biphasic action of NMDA on GnRH mRNA levels. Since NMDA (100 μM) and SNP (1 μM) markedly induced c-jun expression, but not c-fos expression, we hypothesized that Jun activation is responsible for the transcriptional activation of GnRH gene expression. To examine this, we performed two different experiments. Treatment of NMDA greatly increased the activity of heterologous promoter of Fos/Jun responsive sequence (-187/-69) from the mouse GnRH promoter fused to hsv-tk minimal promoter. Moreover, overexpression of c-jun induced GnRH promoter activity, while c-fos overexpression decreased GnRH promoter activity. Taken together, this study indicates that NMDA regulates GnRH gene expression in GT1-1 cells through the NO-Jun signal transduction pathway. Copyright (C) 1998 Elsevier Science B.V.

KW - Fos

KW - GnRH

KW - GT1-1 cell

KW - Jun

KW - Nitric oxide

KW - NMDA

UR - http://www.scopus.com/inward/record.url?scp=0032582594&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032582594&partnerID=8YFLogxK

U2 - 10.1016/S0169-328X(98)00227-7

DO - 10.1016/S0169-328X(98)00227-7

M3 - Article

VL - 61

SP - 162

EP - 169

JO - Brain Research

JF - Brain Research

SN - 0006-8993

IS - 1-2

ER -